The coronavirus variant discovered in South Africa can break through the protection provided by Pfizer Inc and BioNTech's COVID-19 vaccine to some extent, a real-world data study in Israel found. However, the variant's prevalence in Israel is very low and the vaccine remains highly effective.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,